Unlocking Pain Therapeutics: How to Find the Right Target and Treatment Approach
Abstract
The approval of the selective NaV1.8 inhibitor Suzetrigine for acute pain has renewed optimism for developing novel analgesics, yet the clinical failure of its successor VX993 highlights the persistent difficulty of translating promising pain targets into effective therapies. This review examines why progress has been limited and how modern human centered approaches can reshape pain drug discovery. Human genetic studies from large biobanks demonstrate that genetically supported targets have a higher likelihood of clinical success. However, for pain, the relationship between genetic association and therapeutic efficacy is complex. Rare mutations in NaV1.7 and NaV1.8 strongly validate these channels as valid pain targets, yet common variant studies reveal little association with chronic pain risk, underscoring a polygenic and pathway level architecture rather than single gene causation. Human transcriptomic atlases of dorsal root ganglia (DRG) reveal extensive redundancy across NaV channel isoforms, helping explain the modest efficacy of selective NaV1.8 inhibition and pointing toward the need for multi target or pathway wide approaches. Multiomic analyses in osteoarthritis highlight additional pain generating mechanisms, including synovial inflammation, neuroimmune interactions, metabolic dysregulation, and osteoclast activity, along with the involvement of specific nociceptor subtypes. Human DRG electrophysiology and PK/PD modeling show that Suzetrigine achieves high NaV1.8…
Read the paper
Related studies
- Noninvasive and Point-of-Care Surface-Enhanced Raman Scattering (SERS)-Based Breathalyzer for Mass Screening of Coronavirus Disease 2019 (COVID-19) under 5 min
- De Novo Transcriptome Analysis and Detection of Antimicrobial Peptides of the American Cockroach Periplaneta americana (Linnaeus)
- Molecular Characterization and Expression Profiling of Tomato GRF Transcription Factor Family Genes in Response to Abiotic Stresses and Phytohormones
- Assembly of Tight Junction Strands: Claudin-10b and Claudin-3 Form Homo Tetrameric Building Blocks that Polymerise in a Channel-Independent Manner
- Update of the Pompe variant database for the prediction of clinical phenotypes: Novel disease‐associated variants, common sequence variants, and results from newborn screening
- Machine Learning-Based SERS Chemical Space for Two-Way Prediction of Structures and Spectra of Untrained Molecules
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.